| abstract |
[PROBLEMS] To suppress post-prandial hyperglycemia (or glucose intolerance) by inhibiting SGLT1 activity and suppressing absorption of glucose and the like in the small intestine, thereby preventing, for example, diabetes and A 4-isopropylphenyl glucitol compound capable of suppressing the onset of metabolic syndrome or treating those diseases is provided. A 4-isopropylphenyl glucitol compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof. [Chemical 1] In the formula, R 1 represents a hydrogen atom or the like, R 2 represents a methyl group or the like, R 3 represents a C 1-4 alkyl group or the like substituted with an amino group, and R 4 represents a hydrogen atom or the like. [Selection figure] None |